Results 201 to 210 of about 1,181,836 (211)
Some of the next articles are maybe not open access.

Efficacy and safety of CT-P13 (infliximab biosimilar) over two years in patients with ankylosing spondylitis: comparison between continuing with CT-P13 and switching from infliximab to CT-P13

Arthritis & Rheumatism, 2013
Park, Won   +12 more
openaire  

Implementation of CT-P13 via a Managed Switch Programme in Crohn’s Disease: 12-Month Real-World Outcomes

Digestive Diseases and Sciences, 2018
Nikolas Plevris   +2 more
exaly  

Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months

Digestive Diseases and Sciences, 2017
Federico Argüelles-Arias   +2 more
exaly  

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

Annals of the Rheumatic Diseases, 2017
B. Glintborg   +23 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy